Serotonin–norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption
- 29 January 2013
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 24 (5) , 1741-1749
Abstract
Antidepressants are associated with bone loss and fractures in older adults. We treated depressed older adults with an antidepressant and examined its effects on bone turnover by comparing blood samples before and after treatment. Bone resorption increased after antidepressant treatment, which may increase fracture risk.Keywords
This publication has 52 references indexed in Scilit:
- Use of Antidepressant Medications and Risk of Fracture in Older WomenCalcified Tissue International, 2011
- Risk of Low Bone Mineral Density Associated With Psychotropic Medications and Mental Disorders in Postmenopausal WomenJournal of Clinical Psychopharmacology, 2011
- Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levelsBone, 2010
- The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)Bone, 2010
- Sample sizes required to detect interactions between two binary fixed-effects in a mixed-effects linear regression modelComputational Statistics & Data Analysis, 2009
- A detailed examination of cytokine abnormalities in Major Depressive DisorderEuropean Neuropsychopharmacology, 2008
- Depressive Symptoms, Bone Loss, and Fractures in Postmenopausal WomenJournal of General Internal Medicine, 2008
- Depression induces bone loss through stimulation of the sympathetic nervous systemProceedings of the National Academy of Sciences, 2006
- The Association of Bone Mineral Density and Depression in an Older PopulationJournal of the American Geriatrics Society, 2001
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979